These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30252138)

  • 1. Quantitative profiling of cytokines and chemokines in DOCK8-deficient and atopic dermatitis patients.
    Jacob M; Bin Khalaf D; Alhissi S; Arnout R; Alsaud B; Al-Mousa H; Lopata AL; Alazami AM; Dasouki M; Abdel Rahman AM
    Allergy; 2019 Feb; 74(2):370-379. PubMed ID: 30252138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
    Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
    Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry biomarkers distinguish DOCK8 deficiency from severe atopic dermatitis.
    Janssen E; Tsitsikov E; Al-Herz W; Lefranc G; Megarbane A; Dasouki M; Bonilla FA; Chatila T; Schneider L; Geha RS
    Clin Immunol; 2014 Feb; 150(2):220-4. PubMed ID: 24440647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children.
    Hagl B; Heinz V; Schlesinger A; Spielberger BD; Sawalle-Belohradsky J; Senn-Rauh M; Magg T; Boos AC; Hönig M; Schwarz K; Dückers G; von Bernuth H; Pache C; Karitnig-Weiss C; Belohradsky BH; Frank J; Niehues T; Wahn V; Albert MH; Wollenberg A; Jansson AF; Renner ED
    Pediatr Allergy Immunol; 2016 Mar; 27(2):177-84. PubMed ID: 26592211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics Profiling to Distinguish DOCK8 Deficiency From Atopic Dermatitis.
    Jacob M; Masood A; Shinwari Z; Abdel Jabbar M; Al-Mousa H; Arnaout R; AlSaud B; Dasouki M; Alaiya AA; Abdel Rahman AM
    Front Allergy; 2021; 2():774902. PubMed ID: 35386989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency.
    Engelhardt KR; Gertz ME; Keles S; Schäffer AA; Sigmund EC; Glocker C; Saghafi S; Pourpak Z; Ceja R; Sassi A; Graham LE; Massaad MJ; Mellouli F; Ben-Mustapha I; Khemiri M; Kilic SS; Etzioni A; Freeman AF; Thiel J; Schulze I; Al-Herz W; Metin A; Sanal Ö; Tezcan I; Yeganeh M; Niehues T; Dueckers G; Weinspach S; Patiroglu T; Unal E; Dasouki M; Yilmaz M; Genel F; Aytekin C; Kutukculer N; Somer A; Kilic M; Reisli I; Camcioglu Y; Gennery AR; Cant AJ; Jones A; Gaspar BH; Arkwright PD; Pietrogrande MC; Baz Z; Al-Tamemi S; Lougaris V; Lefranc G; Megarbane A; Boutros J; Galal N; Bejaoui M; Barbouche MR; Geha RS; Chatila TA; Grimbacher B
    J Allergy Clin Immunol; 2015 Aug; 136(2):402-12. PubMed ID: 25724123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis.
    Kasap N; Celik V; Isik S; Cennetoglu P; Kiykim A; Eltan SB; Nain E; Ogulur I; Baser D; Akkelle E; Celiksoy MH; Kocamis B; Cipe FE; Yucelten AD; Karakoc-Aydiner E; Ozen A; Baris S
    Clin Immunol; 2021 Feb; 223():108645. PubMed ID: 33301882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dedicator of cytokinesis 8-deficient CD4
    Tangye SG; Pillay B; Randall KL; Avery DT; Phan TG; Gray P; Ziegler JB; Smart JM; Peake J; Arkwright PD; Hambleton S; Orange J; Goodnow CC; Uzel G; Casanova JL; Lugo Reyes SO; Freeman AF; Su HC; Ma CS
    J Allergy Clin Immunol; 2017 Mar; 139(3):933-949. PubMed ID: 27554822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics Distinguishes DOCK8 Deficiency from Atopic Dermatitis: Towards a Biomarker Discovery.
    Jacob M; Gu X; Luo X; Al-Mousa H; Arnaout R; Al-Saud B; L Lopata A; Li L; Dasouki M; Rahman AMA
    Metabolites; 2019 Nov; 9(11):. PubMed ID: 31718082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human hyper-IgE syndrome: singular or plural?
    Zhang Q; Boisson B; Béziat V; Puel A; Casanova JL
    Mamm Genome; 2018 Aug; 29(7-8):603-617. PubMed ID: 30094507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous manifestations of DOCK8 deficiency syndrome.
    Chu EY; Freeman AF; Jing H; Cowen EW; Davis J; Su HC; Holland SM; Turner ML
    Arch Dermatol; 2012 Jan; 148(1):79-84. PubMed ID: 21931011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DOCK8: regulator of Treg in response to corticotropin-releasing hormone.
    Jin S; Shin JU; Noh JY; Kim H; Kim JY; Kim SH; Kim JH; Park CO; Lee N; Lee H; Lee JS; Lee KH
    Allergy; 2016 Jun; 71(6):811-9. PubMed ID: 26799599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes T
    Keles S; Charbonnier LM; Kabaleeswaran V; Reisli I; Genel F; Gulez N; Al-Herz W; Ramesh N; Perez-Atayde A; Karaca NE; Kutukculer N; Wu H; Geha RS; Chatila TA
    J Allergy Clin Immunol; 2016 Nov; 138(5):1384-1394.e2. PubMed ID: 27350570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ILC3 deficiency and generalized ILC abnormalities in DOCK8-deficient patients.
    Eken A; Cansever M; Okus FZ; Erdem S; Nain E; Azizoglu ZB; Haliloglu Y; Karakukcu M; Ozcan A; Devecioglu O; Aksu G; Arikan Ayyildiz Z; Topal E; Karakoc Aydiner E; Kiykim A; Metin A; Cipe F; Kaya A; Artac H; Reisli I; Guner SN; Uygun V; Karasu G; Dönmez Altuntas H; Canatan H; Oukka M; Ozen A; Chatila TA; Keles S; Baris S; Unal E; Patiroglu T
    Allergy; 2020 Apr; 75(4):921-932. PubMed ID: 31596517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation.
    Bittner TC; Pannicke U; Renner ED; Notheis G; Hoffmann F; Belohradsky BH; Wintergerst U; Hauser M; Klein B; Schwarz K; Schmid I; Albert MH
    Klin Padiatr; 2010 Nov; 222(6):351-5. PubMed ID: 21058221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for DOCK8 deficiency-related severe dermatitis.
    Ollech A; Mashiah J; Lev A; Simon AJ; Somech R; Adam E; Barzilai A; Hagin D; Greenberger S
    J Dermatol; 2021 Sep; 48(9):1386-1393. PubMed ID: 34043252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients.
    Alsum Z; Hawwari A; Alsmadi O; Al-Hissi S; Borrero E; Abu-Staiteh A; Khalak HG; Wakil S; Eldali AM; Arnaout R; Al-Ghonaium A; Al-Muhsen S; Al-Dhekri H; Al-Saud B; Al-Mousa H
    J Clin Immunol; 2013 Jan; 33(1):55-67. PubMed ID: 22968740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transcription factor EPAS1 links DOCK8 deficiency to atopic skin inflammation via IL-31 induction.
    Yamamura K; Uruno T; Shiraishi A; Tanaka Y; Ushijima M; Nakahara T; Watanabe M; Kido-Nakahara M; Tsuge I; Furue M; Fukui Y
    Nat Commun; 2017 Jan; 8():13946. PubMed ID: 28067314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis.
    Tavassoli M; Abolhassani H; Yazdani R; Ghadami M; Azizi G; Abdolrahim Poor Heravi S; Moeini Shad T; Kokabee M; Movahedi M; Abdshahzadeh H; Gharagozlou M; Rezaei N; Esmaeilzadeh H; Aleyasin S; Aghamohammadi A
    Pediatr Allergy Immunol; 2019 Jun; 30(4):469-478. PubMed ID: 30801830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome.
    Zhang Q; Davis JC; Dove CG; Su HC
    Dis Markers; 2010; 29(3-4):131-9. PubMed ID: 21178272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.